Results 131 to 140 of about 7,935 (218)

Defining Disabling Disease in Moderate-to-Severe Ulcerative Colitis: Beyond Treatment Escalation. [PDF]

J Gastroenterol Hepatol
Abubakar M, Usman M.
europepmc   +1 more source

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis. [PDF]

Aliment Pharmacol Ther
Eldesouki MH, Ibrahim A, Marey MM, Francis FF, Alsakarneh S, Ayala E, Shaukat A, Farraye FA, Hashash JG.   +8 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. [PDF]

Clin Pharmacol Ther
Maillard M, Schwab M, Whirl-Carrillo M, Moyer AM, Suarez-Kurtz G, Pui CH, Stein CM, Klein TE, Spahn C, Kwon S, Hartono JL, de Boer NK, Ahmad T, Antillon-Klussmann FG, Caudle KE, Kato M, Yeoh AEJ, Schmiegelow K, Yang JJ.   +18 more
europepmc   +1 more source

Population frequencies of thiopurine-related pharmacogenes in healthy individuals from Kosovo. [PDF]

Hum Genome Var
Pasha F, Urbančič D, Gosheva G, Zhubi B, Maliqi Qormemeti S, Krasniqi S, Mlinarič-Raščan I.   +6 more
europepmc   +1 more source

Vedolizumab as a first-choice biological treatment of Crohn's disease in a patient with paraganglioma of the nervous system. [PDF]

Prz Gastroenterol
Szałwińska P, Ewa Malecka- W.
europepmc   +1 more source

Inflammatory bowel disease treatment: Mechanisms to clinical translation (Review). [PDF]

Int J Mol Med
Tang S, Gou G, Liu Y, Wang F, Shu F, Deng Y, Zhang T, Xu J, Xie R.   +8 more
europepmc   +1 more source

The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program. [PDF]

Ther Adv Gastroenterol
Rubin DT, Lees CW, Baert F, Kudela M, Bhattacharjee A, Lazin K, Goetsch M, Abbatemarco AM, Wosik K, Marshall JK.   +9 more
europepmc   +1 more source

Clarifying Composite Outcomes and Baseline Prognostic Analysis in Ulcerative Colitis. [PDF]

J Gastroenterol Hepatol
Lee CK.
europepmc   +1 more source

From Disease Trajectories to Treatment Decisions in Ulcerative Colitis: Treatment-Aware Validation Is Needed. [PDF]

J Gastroenterol Hepatol
Chen TY.
europepmc   +1 more source